Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18191200 | 1.00 | FDPS (0.33) | FDPS | |
| SCHEMBL7678871 | 0.79 | FDPS (0.36) | FDPS | |
| SCHEMBL7678001 | 0.79 | FDPS (0.38) | FDPS | |
| SCHEMBL7674251 | 0.77 | CYP1A2 (0.30) | — | |
| SCHEMBL7679803 | 0.75 | MMP1 (0.33) | — | |
| SCHEMBL2234480 | 0.74 | — | — | |
| SCHEMBL2563954 | 0.72 | — | — | |
| SCHEMBL7679149 | 0.70 | — | — | |
| SCHEMBL949310 | 0.69 | — | — | |
| SCHEMBL10367451 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| EP-3581583-B1 | PHARMACEUTICAL COMPOUND | VALLAURIX PTE LTD (SG) | 2022-02-23 | — | — | EP | disclosed |
| EP-3581582-B1 | PHARMACEUTICAL COMPOUND | VALLAURIX PTE LTD (SG) | 2021-03-31 | — | — | EP | disclosed |
| US-20200095303-A1 | PHARMACEUTICAL COMPOUND | VALLAURIX PTE. LTD. (SG) | 2020-03-26 | — | — | US | disclosed |
| US-20180094039-A1 | PHARMACEUTICAL COMPOUND | VALLAURIX PTE. LTD. (SG) | 2018-04-05 | — | — | US | disclosed |
| EP-3288966-A1 | PHARMACEUTICAL COMPOUND | VALLAURIX PTE. LTD. (SG) | 2018-03-07 | — | — | EP | disclosed |
| WO-2016174611-A1 | PHARMACEUTICAL COMPOUND | VALLAURIX PTE. LTD. (SG) | 2016-11-03 | — | — | WO | disclosed |
| EP-3088417-A1 | PHARMACEUTICAL COMPOUND | VALLAURIX PTE. LTD. (SG) | 2016-11-02 | — | — | EP | disclosed |
| CN-102307857-A | High penetration compositions and their use | CHONGXI YU | 2012-01-04 | — | — | CN | disclosed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | disclosed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | disclosed |